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Nonanastomotic pseudoaneurysms most com-
monly occur after iatrogenic trauma. Most of these
aneurysms are located in the femoral arteries after
catheterization. The standard mode of treatment
for these aneurysms had been immediate surgical
repair. Since its initial description by Fellmeth el al1
in 1991, ultrasound-guided compression repair
(UGCR) has allowed nonoperative treatment for
most patients. In this procedure, pressure is applied
with the ultrasound transducer over the center of the
neck of the pseudoaneurysm until the flow through
the neck is arrested. Pressure is maintained for 10 to
20 minutes and then slowly released. If flow is still
present, compression is immediately resumed. This
cycle is repeated until the flow in the pseudo-
aneurysm is eliminated. Dozens of reports have been
published that verify the efficacy and overall safety of
this procedure. The typical success rate is between
60% and 90%.2-7 UGCR is a good alternative to sur-
gical repair and has become the primary method of
treatment in many institutions. However, the proce-
dure is time-consuming and painful, has poor results
with patients who are undergoing anticoagulation
therapy, and cannot treat noncompressible pseudo-
aneurysms.
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Purpose: We previously reported preliminary data on a new procedure that we developed
for the treatment of femoral pseudoaneurysms after catheterization. This study presents
our current results of percutaneous ultrasound-guided thrombin injection for treating
pseudoaneurysms that arise from various locations and causes.
Methods: Between February 1996 and May 1999, we performed thrombin injection of
83 pseudoaneurysms in 82 patients. There were 74 femoral pseudoaneurysms: 60 from
cardiac catheterization (36 interventional), seven from peripheral arteriography (four
interventional), five from intra-aortic balloon pumps, and two from dialysis catheters.
There were nine other pseudoaneurysms: five brachial (two cardiac catheterization, two
gunshot wounds, one after removal of an infected arteriovenous graft), one subclavian
(central venous catheter insertion), one radial (arterial line), and one distal superficial
femoral and one posterior tibial (both after blunt trauma). Twenty-nine pseudo-
aneurysms were injected while on therapeutic anticoagulation. Patients underwent
repeat ultrasound examination within 5 days and after 4 weeks.
Results: Eighty-two of 83 pseudoaneurysms had initial successful treatment by this tech-
nique, including 28 of 29 in patients who were undergoing anticoagulation therapy. The
only complication was thrombosis of a distal brachial artery, which resolved sponta-
neously. There were early recurrences in seven patients: four patients underwent suc-
cessful reinjection; reinjection failed in two patients, who underwent surgical repair; and
one patient had spontaneous thrombosis on follow-up. After 4 weeks, ultrasound exam-
inations were completely normal or showed some residual hematoma, and there were no
recurrent pseudoaneurysms.
Conclusion: Ultrasound-guided thrombin injection of pseudoaneurysms has excellent
results, which support its widespread use as the primary treatment for this common
problem. (J Vasc Surg 2000;31:289-98.)
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Because of the shortcomings of UGCR, in 1996
we developed a new method of treating femoral
pseudoaneurysms after catheterization.8 We have
expanded the application of this procedure to
include pseudoaneurysms that arise from other
arteries and from other causes. The current report
updates our experience with this technique.
PATIENTS AND METHODS
Between February 1996 and May 1999, we
treated 83 pseudoaneurysms in 82 patients. During
the first year of the study, six other patients with
pseudoaneurysms after catheterization did not have
thrombin injection because of referring physician
preference: two patients had successful UGCR, and
four patients underwent surgical repair. After the
first year, all pseudoaneurysms were treated with
thrombin injection except for one femoral pseudo-
aneurysm that was obviously infected and required
surgical repair with an interposition vein graft. We
also excluded all aneurysms that arose from graft-to-
artery anastomoses.
The patients included 42 men and 40 women,
with a mean age of 66 years (range, 24-89 years).
There were 74 femoral pseudoaneurysms in the
groin: 60 occurred after cardiac catheterization (24
diagnostic and 36 interventional); seven, after
peripheral arteriography (four interventional); five,
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Fig 1. Needle placement into a femoral pseudoaneurysm.
Fig 2. Arteriogram of brachial artery performed 3 weeks after a gunshot wound shows a pseudo-
aneurysm.
after intra-aortic balloon catheterization; and two,
after dialysis catheterization. There were nine other
nongroin pseudoaneurysms: five in the brachial
artery (two were after cardiac catheterization; two
were from gunshot wounds, and 1 occurred after
complete removal of an infected arteriovenous graft
with primary arterial repair); one subclavian (after
attempts at central venous catheter insertion); one
radial (arterial line); and one distal superficial
femoral and one posterior tibial (both after motor
vehicle accidents). Of the 78 pseudoaneurysms that
occurred after catheterization, 73 pseudoaneurysms
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Fig 3. A, Duplex ultrasound scan of the same pseudoaneurysm shown in Fig 2. B, B-mode image
clearly shows the defect in the artery, which measured 1.22 cm in length. C, Thrombin injection
has thrombosed the pseudoaneurysm.
A
B C
were injected within 21 days after the catheter was
removed (average, 4.8 days), and five pseudo-
aneurysms were treated 39, 40, 73, 135, and 159
days after the catheter removal. The five non-
catheter-related pseudoaneurysms were treated 5 to
63 days after injury. Twenty-nine pseudoaneurysms
in 28 patients were injected while the patients were
undergoing anticoagulation therapy with heparin or
warfarin.
Diagnostic duplex ultrasound examinations were
performed with an ATL HDI 3000 or HDI 5000
(Advanced Technology Laboratories, Bothell, Wash)
or an Acuson 128XP (Acuson Computed Sonography,
Mountain View, Calif) with a 4- to 7-MHz or 5-MHz
linear array transducer. Width, length, and depth of
the pseudoaneurysm flow cavity were measured.
Pulses and ankle brachial indices were measured before
and after injection.
Thrombin injection was performed as described
in our earlier report.8 The ultrasound transducer was
centered over the pseudoaneurysm. Topical throm-
bin (GenTrac, Middleton, Wis) at a concentration of
1000 U/mL was loaded into a small syringe with a
21-gauge or 22-gauge spinal needle attached. The
needle was inserted at an angle into the pseudo-
aneurysm along the same plane as the transducer
(Fig 1). A needle biopsy guide attached to the trans-
ducer was used on occasion. B-mode imaging was
used to confirm that the needle tip was near the cen-
ter of the pseudoaneurysm. Imaging of the needle
tip appeared to be aided by the small amount of
thrombus that formed on the needle bevel as it
entered the pseudoaneurysm. A needle that is
etched near the tip for enhanced ultrasound visual-
ization (Echotip; Cook, Bloomington, Ind) was
usually used in the latter one half of the series. With
color-flow on, 0.2 to 1 mL of thrombin solution was
slowly injected into the pseudoaneurysm. This
resulted in almost immediate thrombosis of the
pseudoaneurysm. No compression was performed.
When there was incomplete thrombosis, the needle
was redirected into the remaining flow cavity, and
more thrombin was injected.
Initially, patients were kept at bed rest for 1 hour.
Since July 1997, outpatients were allowed to leave
the vascular laboratory immediately. Inpatients were
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Table I. Nonfemoral pseudoaneurysms treated with thrombin injection
Time to
Patient Sex Age (y) Location Cause diagnosis (d) Presentation Comments
1 F 52 R distal brachial Cardiac catheter 5 Pulsatile hematoma, 
extensive ecchymosis, 
falling hematocrit
2 M 73 R distal brachial Cardiac catheter 5 Pulsatile hematoma Development of 
temporary arterial 
thrombosis after 
thrombin injection
3 F 66 L distal brachial Removal infected 63 Pulsatile mass No signs of infection 
AV graft at time of thrombin 
injection
4 M 29 L distal brachial Gunshot wound 17 Arm swelling and Had compartment
bleeding from exit syndrome 5 days
wound after injury, required
forearm fasciotomy 
and subsequent skin 
grafts
5 M 24 L distal brachial Gunshot wound 21 Arm swelling Had humerus fracture 
treated nonoperatively
6 M 72 L distal radial Arterial line 7 Pulsatile hematoma
7 F 53 R mid subclavian Central venous  1 Large expanding Had intra-aortic
catheter supraclavicular hema- balloon pump for
toma, falling hemato- acute MI at time of 
crit thrombin injection
8 M 43 L mid posterior Pedestrian hit by 5 Painful calf swelling Had fixation of spinal 
tibial motor vehicle fracture on day of 
injury; pain stopped 
immediately after 
thrombin injection
9 M 59 L distal superficial Motor vehicle 30 Thigh swelling Had fixation of L ankle 
femoral accident fracture 1 day after
injury
AV, Arteriovenous; MI, myocardial infarction.
discharged the same day, unless other reasons kept
them in the hospital. Repeat duplex examinations
were performed after 1 to 5 days and after 4 weeks. 
RESULTS
Eighty-two of 83 pseudoaneurysms had initial
successful treatment by thrombin injection. The one
failure, which occurred in the second patient in our
series, might have been successful had we given a
second injection; but our protocol at the time
allowed only one injection. One injection was suffi-
cient for complete thrombosis in 58 pseudo-
aneurysms; two or three injections were necessary in
the other 24 pseudoaneurysms. The median total
volume of thrombin injection was 0.6 mL, and the
mean was 0.82 mL (range, 0.2-2.5 mL). The great-
est diameter of the pseudoaneurysm ranged from
1.0 to 13.5 cm, and the calculated volume (length ×
width × depth) was as small as 0.7 cm3 and as large
as 578 cm3. There was no correlation between the
size of the pseudoaneurysm and the amount of
thrombin required for successful thrombosis (R2 =
0.10; P = .39, Pearson correlation). However, the
size of the pseudoaneurysm did predict the likeli-
hood of complete thrombosis after one injection.
The median volume of the 58 pseudoaneurysms that
thrombosed completely after one injection was sig-
nificantly less than that of the 25 pseudoaneurysms
that did not (10.7 cm3 vs 19.0 cm3; P = .02, Mann-
Whitney rank sum test).
Anticoagulation status did not affect the efficacy
of the procedure. Thrombin injection was successful
in 28 of the 29 pseudoaneurysms in patients who
were undergoing anticoagulation therapy at the
time. Patients who were receiving heparin therapy
had a mean partial thromboplastin time of 78.2 sec-
onds (range, 55.8-113.4 seconds); those patients
who were receiving warfarin therapy had a mean
international normalized ratio of 2.81 (range, 1.84-
6.8). There was one early recurrence in these
patients, which was successfully reinjected, and no
recurrences in an additional six patients whose anti-
coagulants were withheld before the procedure and
restarted after successful thrombin injection.
Eighteen patients continued to receive anticoagula-
tion therapy long term (usually for atrial fibrillation
or a prosthetic heart valve).
Thrombin injections of the nine pseudo-
aneurysms outside of the groin were all effective,
even in cases because of blunt or penetrating trauma
(Table I). The subclavian pseudoaneurysm would
have been impossible to compress, and surgical
repair would have likely required a median sternoto-
my for proximal control. Repair of the other arteries
would have been less complex, but both of the gun-
shot wound injuries had features that made surgical
procedures less appealing. The first patient experi-
enced extensive swelling and a fasciotomy wound
with healing skin grafts extending up to the site of
the pseudoaneurysm. This patient had an arterio-
gram that showed a large defect in the brachial
artery (Fig 2). We were concerned that this would
increase the risk of arterial thrombosis. However,
the brachial artery was bifurcated above the
pseudoaneurysm; the uninjured artery supplied the
radial artery, and the palmar arch was patent. Even
with the large defect, thrombin injection was suc-
cessful in occluding the pseudoaneurysm (Fig 3).
The other patient also experienced extensive
swelling and a comminuted distal humerus fracture
that would have complicated an operative repair of
the pseudoaneurysm. This brachial artery also was
bifurcated in the proximal portion, and the palmar
arch was patent.
There were three other brachial pseudo-
aneurysms, two after catheterization and one after
removal of an infected forearm arteriovenous graft.
In the latter, the graft had been removed complete-
ly with primary repair of the arterial defect. Two
months later, the patient had a pulsatile mass over
the artery. The antecubital skin incision had healed
secondarily, and there were no signs of infection.
Thrombin injection successfully obliterated the
pseudoaneurysm, which appeared to arise from a
small defect where the artery had been repaired.
Although this could be considered an anastomotic
pseudoaneurysm, because there was no prosthesis,
we felt it would be able to heal as did our other
pseudoaneurysms.
We had one complication from thrombin injec-
tion.9 After the injection of thrombin into a brachial
pseudoaneurysm after catheterization, the pseudo-
aneurysm was thrombosed; but there was a persis-
tent neck. The needle tip was positioned within this
neck, and less than 0.2 mL of thrombin was inject-
ed with successful thrombosis. However, a few min-
utes later, the patient experienced hand ischemia,
and ultrasound showed thrombus in the distal
brachial artery. Review of the videotape showed that
some of the thrombin solution was injected directly
into the artery. The patient was already receiving a
heparin infusion, and an additional 5000 units were
given. Fewer than 10 minutes later, the patient’s
hand ischemia resolved, and radial and ulnar pulses
had returned. Ultrasound imaging showed partial
lysis of the thrombus with distal flow. Three days
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later, the thrombus in the brachial artery had com-
pletely disappeared, but the pseudoaneurysm
remained thrombosed. Based on this experience, we
did not further inject persistent necks. Nine residual
necks were observed: six had spontaneous thrombo-
sis, and three developed recurrent pseudoaneurysms
within a few days. No other complications were
noted. No other pulse deficits or significant decreas-
es in ankle pressure occurred. The procedure was
not painful, and no patient required any analgesia or
sedation.
Altogether there were early recurrences in seven
patients (five femoral, one brachial, and one posteri-
or tibial). Six recurrent pseudoaneurysms were rein-
jected, but one of the femoral pseudoaneurysms
could not be thrombosed and required operation.
The artery was found to have two defects; the larg-
er defect was more than 10 mm in length. One of
the reinjected pseudoaneurysms recurred again. This
patient had an associated femoral arteriovenous fis-
tula arising from the posterior wall of the artery
opposite the pseudoaneurysm, and both defects
were surgically repaired. The seventh patient had
posterior tibial artery pseudoaneurysm, with partial
recurrence a day after thrombin injection. At the
time the recurrence was diagnosed, none of the vas-
cular surgeons who were participating in the study
were available. Five days later, when the patient
returned for a thrombin injection, the pseudo-
aneurysm had spontaneously thrombosed.
Duplex studies obtained after 4 weeks in 34
patients showed residual thrombus in one half of the
patients and complete resorption of the thrombus in
the other one half. No recurrences or complications
were seen at this time period or later, presumably
because the arterial defects had healed. So overall,
80 of the 83 pseudoaneurysms (96%) were success-
fully treated by thrombin injection; only three
pseudoaneurysms required surgical repair.
DISCUSSION
We have demonstrated that ultrasound-guided
thrombin injection is a good procedure for the treat-
ment of pseudoaneurysms after catheterization in
the groin and probably in other peripheral arteries.
Treatment of noncatheter-related pseudoaneurysms
is also feasible. Thrombin injection has several
advantages over UGCR. It has a higher success rate,
is more comfortable, is less time-consuming, can
treat noncompressible pseudoaneurysms, and is safe.
Anticoagulation does not impair the efficacy of this
procedure, whereas it significantly decreases the suc-
cess rate of UGCR.3-5,10 Compression is also con-
sidered to be inappropriate for long-standing
injuries (greater than 1 month),1 but thrombin
injection was effective in all six pseudoaneurysms
older than 1 month. Because of the simplicity and
safety of our procedure, we have abandoned UGCR
or observation even for cases that would have a high
likelihood of success with the use of these methods,
such as small pseudoaneurysms in patients who were
not undergoing anticoagulation therapy. As with
compression repair, there were early recurrences,
which supported follow-up duplex examinations.
Although we did not routinely repeat duplex exam-
inations beyond the first month, these patients are
followed rather closely by their physicians because of
their underlying medical problems, and we have not
seen any late recurrences. This is probably because
the arterial defect heals, just as in patients who 
do not experience the development of pseudo-
aneurysms after catheterization or who undergo suc-
cessful compression repair.
The use of thrombin for the treatment of
aneurysms has been reported previously. Rogoff and
Stock11 injected thrombin percutaneously into a
previously excluded but still patent common iliac
artery aneurysm. Cope and Zeit12 percutaneously
injected thrombin into a ruptured anastomotic
femoral pseudoaneurysm for temporary control
before the patient was taken for surgical repair. They
also treated a common iliac pseudoaneurysm, a per-
oneal artery pseudoaneurysm after trauma, and a
hepatic artery aneurysm. Walker et al13 injected
thrombin through a catheter that was inserted from
the contralateral groin into a profunda pseudo-
aneurysm that had developed after the treatment of
a femoral neck fracture. All of these procedures
required fluoroscopy and contrast for the localiza-
tion of the aneurysms and for the determination of
a successful thrombosis. Liau et al14 recently
described successful thrombin injection of five
femoral pseudoaneurysms, using a technique similar
to ours. Instead of direct injection of thrombin
through a needle, a catheter was percutaneously
placed into the pseudoaneurysm. Because this
catheter was not visible on ultrasound, its location
within the pseudoaneurysm was confirmed by inject-
ing 1 to 2 mL of saline solution that contains
micro–air bubbles before the thrombin was injected.
Our technique of direct visualization of the needle
tip is simpler and is the method being adopted by
others.15-17
We found no relationship between the size of the
pseudoaneurysm and the amount of thrombin used.
This is probably due to the fact that, in the begin-
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ning, we routinely administered the entire 1 mL of
thrombin solution, except in very small pseudo-
aneurysms; but later on, we stopped the injection as
soon as thrombus formation was seen. However, the
number of injections required was related to
aneurysm size. Large pseudoaneurysms would
sometimes thrombose only part of the cavity away
from the neck, and a second injection into the
remaining cavity was required. Large aneurysms
were also more likely to have more than one lobe,
and sometimes each lobe would require an injection.
The complication we had was due to a technical
error. Intra-arterial thrombosis has not been seen in
our series when the injection is within the pseudo-
aneurysm cavity itself. The high concentration of
thrombin results in almost immediate conversion of
the solution into a solid (thrombus) when it mixes
with relatively stagnant blood. Because the neck of
the pseudoaneurysm is always narrower than the
aneurysm cavity, the thrombus cannot enter the
artery. As long as the volume of the thrombin that is
injected does not approach or exceed the volume of
the pseudoaneurysm, which may result in forcing
some of the solution out of the cavity, the risk of
native artery thrombosis should be small.
There is a report of thrombosis of the artery after
successful thrombin injection of a brachial pseudo-
aneurysm in a baby.16 In our opinion, this was prob-
ably due to the very small size of the artery with a rel-
atively large defect.9 After thrombin injection of the
pseudoaneurysm, thrombus would be exposed on
the luminal surface at the site of the arterial defect.
This defect should eventually heal and endothelialize,
but in a small artery early intraluminal thrombosis
may occur. Therefore thrombin injection should be
cautiously used for small arteries. Short-term antico-
agulation at the time of thrombin injection might
decrease the risk of intraluminal thrombosis.
Although we advocate broader use of this proce-
dure, treatment of noniatrogenic traumatic pseudo-
aneurysms should be selective. Peripheral pseudo-
aneurysms after blunt trauma may be due to the
tearing of branches. Thrombin injection of such
aneurysms should be safe. Pseudoaneurysms after
knife wounds are probably similar to catheter-relat-
ed pseudoaneurysms, except for the degree of con-
tamination, and should behave similarly. Pseudo-
aneurysms from gunshot wounds may have a higher
failure rate. The hole in the artery is often large.
Pseudoaneurysms with very large defects may have
lower initial success and higher recurrence rates.
There may be an upper limit on the size of arterial
defect that will be amenable to thrombin injection.
There may also be significant adjacent arterial wall
damage from the blast effect that could cause the
initial defect to enlarge over time. Nonetheless, we
have no specific criteria that would absolutely pre-
clude an attempt at thrombin injection. Because
both of our brachial pseudoaneurysms were exam-
ined a few weeks after the gunshot injury, we felt
that the integrity of the adjacent artery wall was
good and that the defect would not further enlarge.
Another potential application of this procedure may
be the treatment of side-branch–related endoleaks
that occur after endovascular abdominal aortic
aneurysm repair. Because the excluded part of the
aneurysm is not easily accessed intravascularly,
thrombin could be percutaneously injected through
a translumbar approach with the use of ultrasound
or computed tomography guidance.
In summary, ultrasound-guided thrombin injec-
tion of pseudoaneurysms after catheterization has
excellent results, which supports its widespread use
as the primary treatment for this common problem.
It may also be suitable for a variety of other iatro-
genic and traumatic pseudoaneurysms. 
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Dr Michel S. Makaroun (Pittsburgh, Pa). It is not
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You recommend a second injection in the occasional
persistent cavity at the neck of the aneurysm. We have
found that a very short period of compression is actually
very effective in the obliteration of this cavity after throm-
bosis of the aneurysm has started with thrombin. It has
also been very effective in one small recurrence we had.
Have you used both techniques in the same patient or do
you think they are mutually exclusive? 
We have encountered, on a few occasions, the quick
formation of a clot inside the needle, not just on the out-
side, that prevented the actual injection. The exact loca-
tion of the tip is sometimes very hard to ascertain when
you have very large complex hematomas surrounding the
pseudoaneurysm. Do you have any tips to avoid these
technical problems? 
And last, our cost analysis shows considerable cost sav-
ings to the hospital if this technique is used as the prima-
ry treatment for femoral pseudoaneurysms. However, it
does require the direct involvement of the vascular sur-
geon, when the compression can be performed by a tech-
nician. So far reimbursement for the physician time has
been denied in our environment. Have you been more
successful in obtaining reimbursement? 
Dr Kang. The brachial artery thrombosis that we had
was a technical mistake, an error in injecting directly into
the neck. The other brachial artery you referred to, which
was reported from England, was a pseudoaneurysm that
was arising from, I think, a very small artery in a 10-
month-old baby. Your suggestion that very small arteries
may not be suitable for injection may be correct. I think
our complication could have occurred in the groin, wher-
ever we had decided to inject into a neck, and that it is not
the brachial artery itself that is the problem there but the
error in injecting into the neck. 
We have had pseudoaneurysms arising from small arter-
ies, including the brachial and the radial and the posterior tib-
ial, and obviously the numbers are smaller. But I think that
every pseudoaneurysm could be treated potentially this way. 
You state that you use a more dilute solution. I am not
sure if that means you are using a smaller total amount of
thrombin, but I think that there is a danger in having a
solution that is too diluted. When fibrinogen is treated
with thrombin, the time that it takes for the liquid to
become a solid depends partly on the thrombin concen-
tration. In the laboratory, when I was a vascular fellow
working with Howard Greisler, a final thrombin concen-
tration of 0.32 units/mL, which is what we used for fibrin
glue, caused this solution to clot in 5 to 7 minutes; that is
not the kind of situation we would like to have occurring
in a pseudoaneurysm. A final concentration in vitro of 32
units/mL caused instantaneous solidification of the fib-
rinogen solution. So there is probably some minimum
amount of thrombin you do want to inject. Our concen-
tration of 1000 units/mL allows us to inject volumes that
are as small as 0.2 mL, and that certainly is going to
reduce the chance that you are going to overinject vol-
umewise and squeeze thrombin solution out into the
artery. 
You talked about compressing residual necks. We elect-
ed to watch residual necks after our complication. Nine
residual necks were observed, and three of them, which
were all successfully reinjected, did lead to a recurrent
pseudoaneurysm in the early period. Nobody in our labo-
ratory wants to perform compression anymore, and I could
not get them to perform compression on residual necks
even if I thought that was the better way of doing it.
The tip location is crucial for you to be sure that you
are in the pseudoaneurysm and not in the artery. As I
mentioned in the article, an echo-tip type of needle will
help you see the tip. The other thing is that you have to
be very careful that you stay in the exact same plane as the
transducer image. If you are off the plane a little, you
might not see it at all. The use of the biopsy guide in that
case does help you to stay in the plane. I understand that
there is new needle technology that is being developed
with different kinds of coatings that may also help in visu-
alizing the tip of the needle. The thrombus that forms in
the bevel is helpful. Obviously, if it forms thrombus in the
whole needle itself and you cannot inject, it is a problem.
I keep my thumb on the back plunger to make sure that
the arterial pressure is not going to cause blood to get into
the needle and syringe. That is also one of the advantages
of using a smaller gauge needle. A 19-gauge needle, for
example, would be more easily seen on ultrasound scan
but more likely to back up into the syringe. 
About reimbursement, we have been charging for
putting a needle into an extremity artery, but I really do
not know how much we have been reimbursed in our own
institution. I think eventually there will be a separate code
for the procedure and maybe someone will set up a reim-
bursement number. 
Dr Glenn M. LaMuraglia (Boston, Mass). As you
probably know, the cardiologists, who are probably our
biggest referrals for this type of problem, have stopped
using heparin, which we have noted has significantly
decreased the incidence of these pseudoaneurysms. And
now, the anticoagulation for their interventions is primar-
ily aspirin and clopidogrel (Plavix) at our institution. And
we have noticed a significant decrease, which, without the
heparin on board, we have actually used C clamps blindly,
which we train the nurses to do. You know, on physical
examination, we are suspicious of that even before we get
an ultrasound scan and have found a reasonable success
rate of loss of bruits and other signs of the fact that we
were successful in occluding these. 
The question that I have is the concern that a lot of our
cardiologists have for injecting thrombin in a patient who
has had an intervention. If you have a left anterior descend-
ing artery stent and the patient is tenuous after a myocar-
dial infection and you are worried about the stent occlud-
ing, the effect that thrombin has in activating platelets is a
major concern by our cardiologists and hematologists.
Would you like to discuss this point for us, please?
Dr John Blebea (Hershey, Pa). Has this now de facto
become the standard for us? When we instituted the pro-
cedure at Penn State, we instituted it under an
Institutional Review Board (IRB) proposal with a rather
long informed concept form. Yet at the same time, we
have received quite a number of phone calls from cardiol-
ogists, radiologists, and other surgeons in the community,
asking us about this technique: How do we do it? I have
recommended to them to establish a formal protocol, to
get the IRB approval, and to proceed under those circum-
stances. But by the time I finish the conversation on the
phone, I get the impression that that is not at all what they
are going to do. When they hang up the phone, I get the
feeling that they are going back there and drawing up the
thrombin and proceeding on their merry way. Do you
believe this now to be the standard of care in these situa-
tions? Should IRB approval and protocols be established?
And if that is true, do you have any recommendations
regarding what we do about our other colleagues in other
specialties who probably are not going to proceed along
those lines and just go ahead and do them? Should there
be an educational protocol or at least a format for other
people before they just start injecting pseudoaneurysms?
Dr Michael S. Conte (Boston, Mass). Will you do this
procedure if you see duplex evidence of an associated arte-
riovenous fistula? 
The cautionary comment I want to make concerns a
recent experience at our institution where, during the last
year, under IRB guidelines, we did start this protocol. Our
vascular medicine colleagues have been following the pro-
cedure you outlined. Recently we had a patient who, after
cardiac surgery, had a persistent pseudoaneurysm, which
was injected with thrombin under ultrasound guidance.
Within minutes the patient had a dramatic cardiopul-
monary event and was taken to the operating room where
the patient underwent an emergent pulmonary embolec-
tomy. After the institution of cardiopulmonary bypass, 
as you might expect, the groin developed a massive
hematoma, and we were called in. When we explored the
artery, after clamping and controlling it, we found that
there were two holes that were adjacent to the femoral
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vein, although we did not directly see a hole in the vein,
as we often do not in such acute circumstances. The ques-
tion remains whether or not this was a complication relat-
ed to an arteriovenous fistula or a direct intravenous injec-
tion, which I think is less likely. After a look at the duplex
scan, the pseudoaneurysm was obvious, and the needle
was in place. This patient actually died. 
Do you know of anyone in the country who has done
this in association with an arteriovenous fistula? We do not
know for sure whether that was relevant in this patient,
but we certainly are worried about it and are going to be
thinking a lot more about doing this procedure, which is
a relatively simple operative approach that is available for
most of these patients.
Dr Kang. The first questions were in regard to the
platelet activation after thrombin injection. As Dr
LaMuraglia mentioned, thrombin is a very potent activator
of platelets. I do think that the amount of thrombin that
gets into the circulation is too small to have systemic
effects. We have a small amount of data on the measure-
ment of platelet activation in patients before and after
thrombin injection with the use of a fluorescence-activated
cell sorter. These data are not complete, but so far there is
no evidence that there is any platelet activation occurring
in the peripheral blood of patients after thrombin injection. 
Our cardiologists are using C clamps. They are also
using closure devices, but they still fail on occasion, so we
do get pseudoaneurysms no matter what anticoagulation
regimen or postprocedure compression methods are used.
We took more than 3 years to accumulate these 83 pseudo-
aneurysms, and we have a very large practice in cardiac
surgery. So I think that it is true that the decreased level of
anticoagulation has resulted in fewer pseudoaneurysms
being detected and treated, but they will not go away. 
Dr Blebea asked if this is a standard of treatment now.
Well, that is what I am proposing here. There are a couple
of other papers that have been published on this proce-
dure, and several others that have been presented. I do
think that in a year or two, when there is enough literature
to support this method, then you should not need an IRB
protocol. It is just like many of the other procedures that
we do in medicine. There is no formal Food and Drug
Administration approval for many of these indications, but
it is accepted as a standard procedure, and I think that will
happen. 
Concerning the education protocol for this procedure,
it is a pretty simple procedure. I am not sure I could teach
a monkey to do it, but I can teach most cardiologists and
ultrasonographers to do it. 
The last questions were about an arteriovenous fistu-
la. Four or five of our patients did have arteriovenous fis-
tulas in association with the pseudoaneurysm. We injected
all of them. The one failure that we had initially was in a
patient who had an arteriovenous fistula that arose from
the pseudoaneurysm. One of our late failures, in whom
surgical repair was required, had an arteriovenous fistula
that arose from the artery opposite the pseudoaneurysm.
I am not sure whether that means that arteriovenous fis-
tulas will make success less likely; but if the thrombus
forms and is trapped in the cavity, the hole in the vein is
also usually not very large. You will not see many occasions
where a large thrombus somehow gets through that defect
in the vein and becomes a pulmonary embolus. I do not
know what happened in your patient who died; but, as
you all know, these are sick patients and a lot of them are
going to die whether you treat them or not. Fewer
patients are going to die if you treat them with thrombin
rather than by taking them to the operating room. 
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